Jan S Moreb

Publication Activity (10 Years)

Years Active: 2016-2020
Publications (10 Years): 7

Top Topics

Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Multiple Myeloma

Top Venues

Case reports in hematology

Cardiovascular toxicology

Clinical transplantation

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ziyang Liu, Shuyao Zhang, Biljana Horn, Jan S Moreb
Postautologous stem cell transplantation engraftment syndrome: Improved treatment and outcomes. Clinical transplantation 34 (3) (2020)
Jan S Moreb
Off-target effects of carfilzomib that cause cardiotoxicity. Blood 133 (7) (2019)
Chintan Shah, Yan Gong, Anita Szady, Qian Sun, Carl J Pepine, Taimour Langaee, Alexandra R Lucas, Jan S Moreb
Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors. Cardiovascular toxicology 18 (2) (2019)
Abdullah M Khan, Jameel Muzaffar, Hemant S Murthy, John R Wingard, Jan S Moreb
Corrigendum to "Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features". Case reports in hematology 2019 (2019)
Abdullah M Khan, Jameel Muzaffar, Hermant Murthy, John R Wingard, Jan S Moreb
Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features. Case reports in hematology 2018 (2018)
Jan S Moreb, Michael Byrne, Ilicia Shugarman, Fei Zou, Sican Xiong, William S May, Maxim Norkin, John Hiemenz, Randall Brown, Christopher Cogle, John R Wingard, Jack W Hsu
Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation. Journal of clinical apheresis 33 (1) (2017)
Jan S Moreb, Deniz A Ucar-Bilyeu, Abdullah Khan
Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells. Cancer chemotherapy and pharmacology 79 (2) (2016)